Live

Stocks are rallying as Trump eased fears over China tariffs and Powell. See the latest.

OTC Markets OTCPK - Delayed Quote USD

Aptose Biosciences Inc. (APTOF)

2.4700

0.0000

(0.00%)

As of 9:30:57 AM EDT. Market Open.

Aptose to Present at the 2025 Bloom Burton & Co. Healthcare Investor Conference

SAN DIEGO and TORONTO, April 23, 2025 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX: APS), a clinical-stage precision oncology company developing a tuspetinib (TUS) based triple drug frontline therapy to treat patients with newly diagnosed acute myeloid leukemia (AML), today announced that the Aptose management team will participate in the 2025 Bloom Burton & Co. Healthcare Investor Conference being held in Toronto, May 5-6, 2025. Dr. William G. Rice, Chairman, Pre

GlobeNewswire 5 hours ago

APTOF
0.00%

Performance Overview

Return	APTOF	S&P/TSX Composite index (^GSPTSE)
YTD	-65.69%	-0.31%
1-Year	-93.31%	+11.51%
3-Year	-99.52%	+15.85%